Hanmi Science Co., Ltd.

KSE 008930.KS

Hanmi Science Co., Ltd. Net Income for the year ending December 31, 2023: USD 88.41 M

Hanmi Science Co., Ltd. Net Income is USD 88.41 M for the year ending December 31, 2023, a 61.71% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Hanmi Science Co., Ltd. Net Income for the year ending December 31, 2022 was USD 54.68 M, a 52.12% change year over year.
  • Hanmi Science Co., Ltd. Net Income for the year ending December 31, 2021 was USD 35.94 M, a 73.23% change year over year.
  • Hanmi Science Co., Ltd. Net Income for the year ending December 31, 2020 was USD 20.75 M, a -21.70% change year over year.
  • Hanmi Science Co., Ltd. Net Income for the year ending December 31, 2019 was USD 26.50 M, a 64.50% change year over year.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
KSE: 008930.KS

Hanmi Science Co., Ltd.

CEO Mr. Jong-Hoon Lim
IPO Date Sept. 29, 2005
Location South Korea
Headquarters 14, Wiryeseong-daero
Employees 402
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services. In addition, it operates an online pharmacy; and offers pharmaceutical management automation systems. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is based in Seoul, South Korea.

StockViz Staff

January 16, 2025

Any question? Send us an email